Skip to Content
Merck

Identification of a G-Protein-Independent Activator of GIRK Channels.

Cell reports (2020-06-20)
Yulin Zhao, Peter Man-Un Ung, Gergely Zahoránszky-Kőhalmi, Alexey V Zakharov, Natalia J Martinez, Anton Simeonov, Ian W Glaaser, Ganesha Rai, Avner Schlessinger, Juan J Marugan, Paul A Slesinger
ABSTRACT

G-protein-gated inwardly rectifying K+ (GIRK) channels are essential effectors of inhibitory neurotransmission in the brain. GIRK channels have been implicated in diseases with abnormal neuronal excitability, including epilepsy and addiction. GIRK channels are tetramers composed of either the same subunit (e.g., homotetramers) or different subunits (e.g., heterotetramers). Compounds that specifically target subsets of GIRK channels in vivo are lacking. Previous studies have shown that alcohol directly activates GIRK channels through a hydrophobic pocket located in the cytoplasmic domain of the channel. Here, we report the identification and functional characterization of a GIRK1-selective activator, termed GiGA1, that targets the alcohol pocket. GiGA1 activates GIRK1/GIRK2 both in vitro and in vivo and, in turn, mitigates the effects of a convulsant in an acute epilepsy mouse model. These results shed light on the structure-based development of subunit-specific GIRK modulators that could provide potential treatments for brain disorders.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Pentylenetetrazole
Sigma-Aldrich
R(+)-SCH-23390 hydrochloride, ≥98% (HPLC), solid
Sigma-Aldrich
ML297, ≥98% (HPLC)
Sigma-Aldrich
CGP 55845 hydrochloride, ≥98% (HPLC)
Sigma-Aldrich
(±)-Baclofen, ≥98% (HPLC), solid
Sigma-Aldrich
Valproic acid sodium salt, 98%